ENSG
ENSIGN GROUP, INC
NASDAQ · Healthcare · Medical - Care Facilities · US
$187.38
+2.83%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 5.7B | 5.1B | 4.3B | 3.7B | 3.0B |
| Cost of Revenue | 4.8B | 4.3B | 3.6B | 3.1B | 2.5B |
| Gross Profit | 835.9M | 799.5M | 667.6M | 590.8M | 518.0M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 310.5M | 269.8M | 225.1M | 263.0M | 158.8M |
| General & Admin Expense | 310.5M | 269.8M | 225.1M | 263.0M | 158.8M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 16.2M | 104.3M | 84.1M | 72.4M | 62.4M |
| Total Operating Expenses | 326.8M | 374.1M | 309.3M | 335.4M | 221.2M |
| Cost and Expenses | 5.2B | 4.6B | 3.9B | 3.5B | 2.7B |
| Operating Income (EBIT) | 509.2M | 425.3M | 358.3M | 255.4M | 296.8M |
| Non-Operating | |||||
| Interest Income | 22.1M | 24.5M | 28.7M | 19.2M | 5.0M |
| Interest Expense | 8.1M | 8.0M | 8.3M | 8.1M | 8.9M |
| Net Interest Income | 14.0M | 16.5M | 20.5M | 11.1M | (3.9M) |
| Other Non-Op Income/Expense | 23.4M | 30.3M | 27.8M | 17.4M | (7.7M) |
| Non-Operating Income (excl Interest) | (31.5M) | (38.3M) | (36.1M) | (25.5M) | (1.2M) |
| EBT (Pre-Tax Income) | 532.5M | 455.6M | 386.1M | 272.8M | 289.1M |
| Income Tax Expense | 133.0M | 111.4M | 87.6M | 62.9M | 64.4M |
| Bottom Line | |||||
| Net Income | 399.1M | 344.0M | 298.0M | 209.4M | 224.7M |
| Earnings from Cont. Ops | 399.4M | 344.3M | 298.5M | 209.8M | 224.7M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 399.1M | 344.0M | 298.0M | 209.4M | 224.7M |
| Per Share | |||||
| Basic EPS | $6.91 | $6.00 | $5.26 | $3.76 | $4.09 |
| Diluted EPS | $6.72 | $5.84 | $5.12 | $3.65 | $3.95 |
| Revenue Per Share | $98.13 | $88.26 | $75.20 | $66.94 | $55.12 |
| Shares | |||||
| Basic Shares Outstanding | 57.8M | 57.3M | 56.7M | 55.7M | 54.9M |
| Diluted Shares Outstanding | 59.3M | 58.9M | 58.2M | 57.3M | 56.9M |
| Profitability Metrics | |||||
| EBITDA | 661.2M | 567.9M | 478.5M | 353.2M | 360.4M |
| D&A | 120.6M | 104.3M | 84.1M | 72.4M | 62.4M |
| EBIT | 540.6M | 463.6M | 394.4M | 280.8M | 298.0M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026